Accuracy of the new rapid test for monitoring adalimumab levels.

Cátia RochaJoana AfonsoPaula LagoBruno ArrojaAna I VieiraCláudia Camila DiasFernando Magro

Published in: Therapeutic advances in gastroenterology (2019)

The Quantum Blue® Adalimumab assay can replace the commonly used ELISA-based ADL quantification kits and it is a reliable alternative to these methods. This rapid-test assay enables the quantitative determination of ADL serum trough level in only 15 min. The developed assay allows measurement of ADL over a wide range. Hence, it represents a valuable tool for the clinician to assess the ADL trough level.

Keyphrases

high throughput
rheumatoid arthritis
juvenile idiopathic arthritis
loop mediated isothermal amplification
solid phase extraction
single cell
quantum dots
simultaneous determination